Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients - Xerri, Luc; Huet, Sarah; Venstrom, Jeffrey M.; Szafer-Glusman, Edith; Fabiani, Bettina; Canioni, Danielle; Chassagne-Clément, Catherine; Dartigues-Cuilléres, Peggy; Charlotte, Fréderic; Laurent, Camille; Gelas-Dore, Benedicte; Bolen, Christopher R.; et al. (Human pathology, 2017)
Keywords: Antineoplastic Agents - therapeutic use; Automation; Biomarkers; Biomarkers, Tumor - analysis; Biomarkers, Tumor - genetics; Biopsy; Cancer therapies; CD3 Complex - analysis; CD3 Complex - genetics; Cloning; Cytotoxicity; Disease-Free Survival; Follicular lymphoma; Gene expression; Humans; Image Interpretation, Computer-Assisted; Immunohistochemistry; Immunotherapy; Lymphocytes, Tumor-Infiltrating - drug effects; Lymphocytes, Tumor-Infiltrating - immunology; Lymphoma; Lymphoma, Follicular - drug therapy; Lymphoma, Follicular - genetics; Lymphoma, Follicular - immunology; Lymphoma, Follicular - pathology; Microenvironment; Monoclonal antibodies; Pathology; Patients; Predictive Value of Tests; Prognosis; Rituximab - therapeutic use; RNA, Messenger - genetics; RNAseq; Sequence Analysis, RNA; Studies; T-Lymphocytes - drug effects; T-Lymphocytes - immunology; Targeted cancer therapy; Time Factors; Treatment Outcome; Tumor Microenvironment; Immunohistochemistry; Follicular lymphoma; Prognosis; Microenvironment; RNAseq